U.S. gives failing marks to independent auditors of New York-listed Chinese companies
The accounting arm of the U.S. securities regulator found major problems with work done by two independent auditors for seven of eight Chinese companies it inspected Key Takeaways: The accounting…
Cancer Drug Maker BeiGene Takes Action to Mitigate Delisting Risk
Company has changed auditors in a bid to comply with U.S. law and avoid a potential forced delisting from the Nasdaq Key Takeaways: BeiGene has switched auditors for its New…